Combining two drugs with two CDs for formulation of a dry powder for inhalation
Dry powders for inhalation are evolving to address the challenge of maximizing lung deposition, with growing interest in carrier-free formulations
A forum for researchers, students and applicants in the field of cyclodextrin technology
Dry powders for inhalation are evolving to address the challenge of maximizing lung deposition, with growing interest in carrier-free formulations
A recently reported finding of Canadian researchers proved the specific effect of lysophosphatidic acid (LPA, see the structure below) by